Clinical practice. Uterine fibroids.

A 47-year-old black woman has heavy menstrual bleeding and iron-deficiency anemia.She reports nocturia and urinary frequency. A colonoscopy is negative. Ultrasonography shows a modestly enlarged uterus with three uterine fibroids. She is not planning to become pregnant. How should this case be evaluated and managed?

[1]  D. Baird,et al.  Short-term change in growth of uterine leiomyoma: tumor growth spurts. , 2011, Fertility and sterility.

[2]  D. Dunson,et al.  Why is Parity Protective for Uterine Fibroids? , 2003, Epidemiology.

[3]  S. Bendifallah,et al.  Therapeutic management of uterine fibroid tumors: updated French guidelines. , 2012, European journal of obstetrics, gynecology, and reproductive biology.

[4]  E. Pritts,et al.  Fibroids and Infertility: A Systematic Review of the Evidence , 2001, Obstetrical & gynecological survey.

[5]  J. Dungan.  Growth of uterine leiomyomata among premenopausal black and white women , 2009 .

[6]  Elizabeth A Stewart,et al.  The health disparities of uterine fibroid tumors for African American women: a public health issue. , 2014, American journal of obstetrics and gynecology.

[7]  L. Aaltonen,et al.  MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas , 2011, Science.

[8]  J. Palmer,et al.  Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata. , 2011, The American journal of clinical nutrition.

[9]  C. Ananth,et al.  Uterine Pathology in Women Undergoing Minimally Invasive Hysterectomy Using Morcellation , 2014 .

[10]  D. Spiegelman,et al.  Influence of Body Size and Body Fat Distribution on Risk of Uterine Leiomyomata in U.S. Black Women , 2005, Epidemiology.

[11]  C. Panhuysen,et al.  Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele , 2009, Human Genetics.

[12]  J. Spies,et al.  The impact of uterine artery embolization on ovarian function. , 2013, Journal of vascular and interventional radiology : JVIR.

[13]  K. Schenck-Gustafsson,et al.  EMAS position statement: management of uterine fibroids. , 2014, Maturitas.

[14]  H. Richter,et al.  Tranexamic Acid Treatment for Heavy Menstrual Bleeding: A Randomized Controlled Trial , 2010, Obstetrics and gynecology.

[15]  C. Walker,et al.  Uterine Fibroids: The Elephant in the Room , 2005, Science.

[16]  Anggie Ramírez-Morera,et al.  Mifepristone for uterine fibroids. , 2012, The Cochrane database of systematic reviews.

[17]  B. Gostout,et al.  Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. , 2010, Fertility and sterility.

[18]  Y. Cheong,et al.  Surgical treatment of fibroids for subfertility. , 2012, The Cochrane database of systematic reviews.

[19]  I. Osterloh,et al.  Ulipristal acetate versus leuprolide acetate for uterine fibroids. , 2012, The New England journal of medicine.

[20]  F. Taran,et al.  Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[21]  B. Borah,et al.  The burden of uterine fibroids for African-American women: results of a national survey. , 2013, Journal of women's health.

[22]  A. Di Spiezio Sardo,et al.  The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia. , 2003, Contraception.

[23]  B. Mol,et al.  Progestogens or progestogen-releasing intrauterine systems for uterine fibroids. , 2013, The Cochrane database of systematic reviews.

[24]  M. Munro,et al.  The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. , 2011, Fertility and sterility.

[25]  J. Manson,et al.  A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. , 1998, Fertility and sterility.

[26]  I. Osterloh,et al.  Ulipristal acetate versus placebo for fibroid treatment before surgery. , 2012, The New England journal of medicine.

[27]  K. Kluivers,et al.  Surgical approach to hysterectomy for benign gynaecological disease. , 2005, The Cochrane database of systematic reviews.

[28]  W. Gedroyc,et al.  Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[29]  J. Manson,et al.  Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and Race , 1997, Obstetrics and gynecology.

[30]  M. Noventa,et al.  Magnetic Resonance-Guided Focused Ultrasound Myomectomy , 2014, Reproductive Sciences.

[31]  A. Lu,et al.  Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata. , 2012, American journal of human genetics.

[32]  M. Hickey,et al.  Uterine artery embolization for symptomatic uterine fibroids. , 2012, The Cochrane database of systematic reviews.

[33]  J. Segars,et al.  The estimated annual cost of uterine leiomyomata in the United States. , 2012, American journal of obstetrics and gynecology.

[34]  J. Reekers,et al.  Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. , 2007, Human reproduction.

[35]  D. Olive,et al.  Fibroids and infertility: an updated systematic review of the evidence. , 2009, Fertility and sterility.

[36]  F. Whaley,et al.  Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas. , 2014, Journal of minimally invasive gynecology.

[37]  J. Spies,et al.  Uterine fibroid embolization. , 2006, Techniques in vascular and interventional radiology.

[38]  Huan Song,et al.  Aromatase inhibitors for uterine fibroids. , 2013, The Cochrane database of systematic reviews.

[39]  David B Dunson,et al.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. , 2003, American journal of obstetrics and gynecology.

[40]  H. Yoshikawa,et al.  Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings , 2004, Journal of magnetic resonance imaging : JMRI.

[41]  D. Spiegelman,et al.  Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. , 2004, American journal of epidemiology.

[42]  W. Rocca,et al.  Reassessing hysterectomy. , 2012, Minnesota medicine.

[43]  C. Farquhar,et al.  Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding (Review) , 2018 .

[44]  Myomas and reproductive function. , 2006, Fertility and sterility.

[45]  I. Osterloh,et al.  Long-term treatment of uterine fibroids with ulipristal acetate ☆. , 2014, Fertility and sterility.